# Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients

> **NCT01357642** · PHASE3 · COMPLETED · sponsor: **Amphastar Pharmaceuticals, Inc.** · enrollment: 373 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Epinephrine inhalation aerosol
- **DRUG:** Placebo
- **DRUG:** epinephrine inhalation aerosol

## Key facts

- **NCT ID:** NCT01357642
- **Lead sponsor:** Amphastar Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-11
- **Final completion:** 2011-12
- **Target enrollment:** 373 (ACTUAL)
- **Last updated:** 2016-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01357642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01357642, "Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01357642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*